三七片

  • 网络Sanqi tablets
三七片三七片
  1. 目的建立HPLC法测定三七片中人参皂苷Rg1含量的方法。

    OBJECTIVE To establish an HPLC method to determine ginsenoside Rg_1 in Sanqi Tablets .

  2. 三七片治疗慢性肾炎患者贫血的临床研究

    Clinical Studies on Treating Anemia Caused by Chronic Nephritis with Tablet of Radix Notoginseng

  3. 目的:观察三七片治疗慢性肾炎患者贫血的疗效。

    Objective : To observe the effect of treating anemia caused by chronic nephritis with tablet of Radix Notoginseng .

  4. 结论:三七片具有调节机体造血机能,提高患者外周血红细胞数量的作用。

    Conclusion : The tablet of Radix Notoginseng can adjustment organism function of hematopoiesis and has effect of increasing quantity of peripheral red-cell .

  5. 目的:用血清心肌肌钙蛋白I(CardiacTroponinI,cTnI)作为心肌损伤标记物评价三七总甙片对经皮冠状动脉腔内成形术(percutaneoustranslu-minalcoronaryangioplasty,PTCA)后心肌损伤的保护作用。

    AIM : To evaluate the effect of panax notoginseng ( PNS ) in protecting myocardial injury after percutaneous transluminal coronary angioplasty ( PTCA ) by cardiac troponin I ( cTnI ) used as the marker of myocardial injury .

  6. 三七总甙片与洛汀新治疗早期糖尿病肾病的对比研究

    A contrast study on clinical effect of total saponins of Panax Notoginseng tablet and Lotensin in treating early diabetic nephropathy

  7. RP-HPLC法测定三七总皂苷缓释片中人参皂苷Rg1的含量

    Determination of content of Ginsenosides Rgl in Sustained-release Tables of Panax Notoginsenosides using RP-HPLC

  8. 前言:目的:制备三七总皂苷分散片。

    Objective : To prepare for the total sapogenin disperse tablet of Notoginseng .

  9. 三七总皂苷缓释片的释放性能及体内外相关性研究

    Study on Release of Panax Notoginseng Saponins Sustained-Release Tablets and Its in Vivo-in Vitro Correlation

  10. 分别建立了三七总皂苷缓释片、重楼皂苷分散片的质量标准。

    The quality standard of Panax notoginseng sustained-release tablets and Paris Polyphylla saponin dispersible tablets were different established .

  11. 目的采用新型缓释材料及固体分散技术制备三七总皂苷缓释片。

    Objective To find new slow-release adjuvant materials for preparing Slow-Release Total Notoginsenoside Tablets ( SRTNT ) by the solid-dispersing technology .